168 related articles for article (PubMed ID: 34907845)
1. Increased serum myonectin and irisin levels with myonectin and FNDC5 expressions in polycystic ovary syndrome: a case control study.
Onat T; Inandiklioglu N; Kara M; Serdar Yalvac E; Turkler C; Ciplak B; Altindag MM
J Obstet Gynaecol; 2022 Jul; 42(5):1381-1387. PubMed ID: 34907845
[TBL] [Abstract][Full Text] [Related]
2. Association of decreased myonectin levels with metabolic and hormonal disturbance in polycystic ovary syndrome.
Demir İ; Guler A
Gynecol Endocrinol; 2020 Nov; 36(11):947-950. PubMed ID: 32314610
[TBL] [Abstract][Full Text] [Related]
3. Correlation analysis of myonectin levels with metabolic and hormonal disorders in patients with polycystic ovary syndrome.
Zhang J; Chen L; Ye J
Ann Palliat Med; 2021 Mar; 10(3):3404-3409. PubMed ID: 33752430
[TBL] [Abstract][Full Text] [Related]
4. Free androgen index and Irisin in polycystic ovary syndrome.
Li H; Xu X; Wang X; Liao X; Li L; Yang G; Gao L
J Endocrinol Invest; 2016 May; 39(5):549-56. PubMed ID: 26584566
[TBL] [Abstract][Full Text] [Related]
5. Serum irisin levels in patients with polycystic ovary syndrome.
Bostancı MS; Akdemir N; Cinemre B; Cevrioglu AS; Özden S; Ünal O
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4462-8. PubMed ID: 26698239
[TBL] [Abstract][Full Text] [Related]
6. Circulating Myonectin and Irisin Levels in Gestational Diabetes Mellitus - A Case-control Study.
Onat T; Inandiklioglu N
Z Geburtshilfe Neonatol; 2021 Aug; 225(4):320-326. PubMed ID: 33728620
[TBL] [Abstract][Full Text] [Related]
7. Serum and follicular fluid irisin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with insulin resistance and lipoprotein lipid profiles.
Bousmpoula A; Benidis E; Demeridou S; Kapeta-Kourkouli R; Chasiakou A; Chasiakou S; Kouskouni E; Baka S
Gynecol Endocrinol; 2019 Sep; 35(9):803-806. PubMed ID: 30982370
[TBL] [Abstract][Full Text] [Related]
8. Serum irisin and its regulation by hyperinsulinemia in women with polycystic ovary syndrome.
Adamska A; Karczewska-Kupczewska M; Lebkowska A; Milewski R; Górska M; Otziomek E; Nikolajuk A; Wolczynski S; Kowalska I
Endocr J; 2016 Dec; 63(12):1107-1112. PubMed ID: 27616010
[TBL] [Abstract][Full Text] [Related]
9. Circulating irisin and glucose-dependent insulinotropic peptide are associated with the development of polycystic ovary syndrome.
Chang CL; Huang SY; Soong YK; Cheng PJ; Wang CJ; Liang IT
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2539-48. PubMed ID: 25029417
[TBL] [Abstract][Full Text] [Related]
10. The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome.
Zhang L; Fang X; Li L; Liu R; Zhang C; Liu H; Tan M; Yang G
J Endocrinol Invest; 2018 Dec; 41(12):1401-1407. PubMed ID: 29785700
[TBL] [Abstract][Full Text] [Related]
11. Implications of circulating irisin and Fabp4 levels in patients with polycystic ovary syndrome.
Abali R; Temel Yuksel I; Yuksel MA; Bulut B; Imamoglu M; Emirdar V; Unal F; Guzel S; Celik C
J Obstet Gynaecol; 2016 Oct; 36(7):897-901. PubMed ID: 27184575
[TBL] [Abstract][Full Text] [Related]
12. Serum irisin levels in polycystic ovary syndrome after ovarian drilling.
Foda AA; Foda EA; El-Said ZH
Diabetes Metab Syndr; 2019; 13(2):1463-1468. PubMed ID: 31336507
[TBL] [Abstract][Full Text] [Related]
13. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
[TBL] [Abstract][Full Text] [Related]
14. Effects of serum irisin, neuregulin 4, and weight management on obese adolescent girls with polycystic ovary syndrome.
Cao S; Hu Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34427289
[TBL] [Abstract][Full Text] [Related]
15. Abnormal irisin level in serum and endometrium is associated with metabolic dysfunction in polycystic ovary syndrome patients.
Wang W; Guo Y; Zhang X; Zheng J
Clin Endocrinol (Oxf); 2018 Oct; 89(4):474-480. PubMed ID: 29972694
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of irisin and Meteorin-like protein in PCOS and its correlation with metabolic parameters.
Paczkowska K; Sobczuk J; Zawadzka K; Jędrzejuk D; Zembska A; Konieczny J; Kaszubkiewicz-Wardęga D; Bolanowski M; Daroszewski J
Endokrynol Pol; 2024; 75(2):199-206. PubMed ID: 38646985
[TBL] [Abstract][Full Text] [Related]
17. Higher circulating irisin levels in patients with polycystic ovary syndrome:a meta-analysis.
Wang C; Zhang XY; Sun Y; Hou XG; Chen L
Gynecol Endocrinol; 2018 Apr; 34(4):290-293. PubMed ID: 29069945
[TBL] [Abstract][Full Text] [Related]
18. The Comparison of Irisin, Subfatin, and Adropin in Normal-Weight and Obese Polycystic Ovary Syndrome Patients.
Majeed AA; Al-Qaisi AHJ; Ahmed WA
Iran J Med Sci; 2024 Jun; 49(6):350-358. PubMed ID: 38952638
[TBL] [Abstract][Full Text] [Related]
19. Serum irisin concentrations in lean adolescents with polycystic ovary syndrome.
Bacopoulou F; Athanasopoulos N; Efthymiou V; Mantzou A; Aravantinos L; Vlahopoulos S; Deligeoroglou E
Clin Endocrinol (Oxf); 2018 Apr; 88(4):585-591. PubMed ID: 29368340
[TBL] [Abstract][Full Text] [Related]
20. Effect of Metformin Treatment on Insulin Resistance Markers, and Circulating Irisin in Women with Polycystic Ovarian Syndrome (PCOS).
Masaeli A; Nayeri H; Mirzaee M
Horm Metab Res; 2019 Sep; 51(9):575-579. PubMed ID: 31121610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
